News in the Life Sciences Industry

PRAGUE, April 1, 2019 /PRNewswire/ -- Zentiva Group a.s. is announcing the acquisition of Creo Pharmaceuticals Ltd. in the UK, a subsidiary of Amneal Pharmaceuticals, Inc. (NYSE: AMRX).

TEL AVIV, Israel, April 1, 2019 /PRNewswire/ -- Kanabo Research, a leading innovator of medical-grade cannabis solutions has signed a Memorandum of Understanding (MoU) with German medical cannabis company Four 20 Pharma GmbH.... Read more ››

NEWARK, Del., March 29, 2019 /PRNewswire/ -- W.L. Gore & Associates, Inc. ("Gore"), a global materials science company, announces its intention to participate in two upcoming life sciences conferences. At the Read more ››

HONG KONG, March 29, 2019 /PRNewswire/ -- The International Association for the Study of Insurance Economics, the leading international insurance think tank of the insurance industry, recently published its latest analysis report, Healthcare in Emerging Markets: Exploring the Protection Gaps... Read more ››

BEIJING, March 29, 2019 /PRNewswire/ -- Olivier Brandicourt, Chief Executive Officer of Sanofi, delivered a keynote speech at the 2019 International Pharmaceutical Innovation Forum held on March 26(th).

BRUSSELS, March 28, 2019 /PRNewswire/ -- UCB, a global biopharmaceutical company, announced today that the U.S. Food and Drug Administration (FDA) has approved extending the label for CIMZIA(®) (certolizumab pegol) to include a new indication for the treatment of adults with active... Read more ››

TOKYO, March 28, 2019 /PRNewswire/ -- The Global Health Innovative Technology Fund (GHIT) today announced the appointment of Catherine Ohura as the organization's new CEO and Executive Director. Ohura brings depth and breadth of expertise and invaluable experience working for R&D and Commercial... Read more ››

• €150 million investment over the 2019-2023 period in manufacturing site at Aubonne, Switzerland

TOKYO, March 27, 2019 /PRNewswire/ -- The Global Health Innovative Technology (GHIT) Fund announced today a total of 2.86 billion yen (US$25.8 million*) to support 10 partnerships to develop new lifesaving drugs, vaccines, and diagnostics for malaria, tuberculosis, dengue, leishmaniasis, and... Read more ››

LONDON and ZUG, Switzerland, March 27, 2019 /PRNewswire/ -- Sintetica Limited, a specialist pharmaceutical company delivering injectable anaesthetics and analgesics to patients worldwide, and Primex Pharmaceuticals AG, an innovative global Anaesthesia pharmaceutical company, announced a strategic... Read more ››

It lowers healthcare costs and improves the quality of life for those affected

WELLINGTON, New Zealand, March 26, 2019 /PRNewswire/ -- Volpara Solutions announced today the launch of an expanded agreement enabling the worldwide distribution of its industry-leading Read more ››